Cost-effectiveness of exemestane vs. tamoxifen in post-menopausal women with early breast cancer in Germany

Braun S, Mittendorf T, Greiner W, Dopatka J, von der Schulenburg JM (2007) Value in Health, 10(6). A326.

Download
No fulltext has been uploaded. References only!
Conference Abstract | Published | English

No fulltext has been uploaded

Author
; ; ; ;
Publishing Year
ISSN
PUB-ID

Cite this

Braun S, Mittendorf T, Greiner W, Dopatka J, von der Schulenburg JM. Cost-effectiveness of exemestane vs. tamoxifen in post-menopausal women with early breast cancer in Germany.
Braun, S., Mittendorf, T., Greiner, W., Dopatka, J., & von der Schulenburg, J. M. (2007). Cost-effectiveness of exemestane vs. tamoxifen in post-menopausal women with early breast cancer in Germany. Value in Health, 10(6), A326.
Braun, S., Mittendorf, T., Greiner, W., Dopatka, J., and von der Schulenburg, J. M. (2007).“Cost-effectiveness of exemestane vs. tamoxifen in post-menopausal women with early breast cancer in Germany”.
Braun, S., et al., 2007. Cost-effectiveness of exemestane vs. tamoxifen in post-menopausal women with early breast cancer in Germany.
S. Braun, et al., “Cost-effectiveness of exemestane vs. tamoxifen in post-menopausal women with early breast cancer in Germany”, 2007.
Braun, S., Mittendorf, T., Greiner, W., Dopatka, J., von der Schulenburg, J.M.: Cost-effectiveness of exemestane vs. tamoxifen in post-menopausal women with early breast cancer in Germany. (2007).
Braun, S., Mittendorf, T., Greiner, Wolfgang, Dopatka, J., and von der Schulenburg, J. M. “Cost-effectiveness of exemestane vs. tamoxifen in post-menopausal women with early breast cancer in Germany”., 2007.
This data publication is cited in the following publications:
This publication cites the following data publications:

Export

0 Marked Publications

Open Data PUB

Web of Science

View record in Web of Science®

Search this title in

Google Scholar